Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
iShares $ Corp Bond ETF USD Dist
LQDA | US
35.87
USD-0.16
-0.44%
LQDA | US
About iShares $ Corp Bond ETF USD Dist
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
35.87
Open
35.32
High
36.56
Low
34.92
Liquidia Corporation a biopharmaceutical company develops manufactures and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville North Carolina.
View LessLQDA | US
Risk
73.6
Sharpe
1.99
Luna's Score
54/100
Recommendation
Hold
Luna says (LQDA | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
High Short-term Volatility
Midcap (2B - 10B USD)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
74.8%1 month
73.6%3 months
65.5%6 months
62.4%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
15.42
Debt to equity
0.05
Debt to assets
0.02
Ent. to EBITDA
-9.43
Ent. to rev.
56.39
PEG
-
Other Fundamentals
EBITDA
-95.84M
MarketCap
3.03B
MarketCap(USD)
3.03B
Div. yield
-
Op. margin
-743.29
Erngs. growth
-
Rev. growth
-23.50
Ret. on equity
-181.73
Short ratio
11.41
Short perc.
21.63
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
8.71
Range1M
14.57
Range3M
17.55
Volumes: Market Activity
Rel. volume
0.79
Price X volume
57.52M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -9.43 | 0.53 | Cheaper |
| Ent. to Revenue | 56.39 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 15.42 | 15.55 | Par |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 65.53 | 72.80 | Par |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 3.03B | 3.66B | Par |
